The sugar-free paradox: cardiometabolic consequences of erythritol

Signal Transduct Target Ther. 2023 Jun 16;8(1):251. doi: 10.1038/s41392-023-01504-6.

Kalliopi Pafili^{1

2

3}, Michael Roden^{4

5

6}

¹ Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, 40225, Düsseldorf, Germany.
² German Center for Diabetes Research, Partner Düsseldorf, 85764, München-Neuherberg, Germany.
³ Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, 40225, Düsseldorf, Germany.
⁴ Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, 40225, Düsseldorf, Germany. [email protected].
⁵ German Center for Diabetes Research, Partner Düsseldorf, 85764, München-Neuherberg, Germany. [email protected].
⁶ Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, 40225, Düsseldorf, Germany. [email protected].

No abstract available

MeSH terms